宜宾做激光脱毛多少钱(宜宾瑞蓝玻尿酸隆鼻怎么样) (今日更新中)

The University of Missouri-Kansas City has filed a lawsuit against a former professor, alleging that he stole and sold his graduate student's research for .5 million.The suit, filed this week, says Ashim Mitra swiped a "groundbreaking" drug formulation from the student and stands to gain as much as million more in royalties.Mitra, who has resigned from the university, denied the allegations to CNN.Also named in the lawsuit are Mitra's wife, who worked in her husband's lab, and two pharmaceutical companies that used the invention.The university alleges Mitra worked in secret with the companies to develop the patent, which outlines an innovative way of delivering drugs to the eye using nanotechnologyThe pharmaceutical product has recently received FDA approval, the university said. It's a treatment for dry eye, an ailment common to the elderly.The university's contentionIn a statement to CNN, the university said:"Mitra stole UMKC-owned inventions, sold them to industry, assisted those companies in patenting and commercializing them, denied credit to a deserving student and reaped a personal financial windfall -- all the while concealing his efforts and denying his involvement."The lawsuit seeks to designate the student, Kishore Cholkar, as the rightful inventor to the patent based on his research from 2010.The university policy is that it owns the rights to discoveries made by staff and students while they are working at the university. When commercial rewards are reaped, the inventor is entitled to one-third of the profits and the school keeps the remaining two-thirds, the school said.The professor's reactionReached by phone Thursday, the professor denied the allegations and told CNN that Cholkar doesn't deserve credit for the patent."Everyone is trying to jump in and get a piece of the pie," he said.He said he conceived of the formulation with the drug companies through his private consultancy business, adding that "the student arrived after the patent was signed."Cholkar's work involved a part of the eye not affected by the drug, Mitra said.He added that he's consulting with his lawyers on how best to tackle the lawsuit.Cholkar, the student, now works at a California-based pharmaceutical company. CNN has reached out to Cholkar for comment. 2298

Tiger Woods clinched his fifth Masters and 15th major title to seal one of the greatest comeback stories in sport after overcoming career-threatening back problems.The 43-year-old muscled his way through a tightly packed leaderboard to win by two shots at Augusta for his first major title in 11 years and first Masters win since 2005.It completes a fairytale return for the most dominant player of his generation -- and arguably the best ever -- after enduring "dark times" through injury since 2014.Woods underwent career-saving spine fusion surgery in 2017 and sealed an impressive comeback season last year with his first win for five years.Sunday's thrilling victory puts the former world No.1 just three majors behind the all-time record of Jack Nicklaus.Only fellow American Nicklaus has won more Masters, with six. Woods also joins Nicklaus as the only player to have won the Masters in three different decades after he clinched his first as a 21-year-old in 1997.Woods began the day two shots behind Italy's Francesco Molinari, and rode the roller coaster of a gripping final round to first share the lead after the Italian found the water in front of the short 12th.Two holes later five players were tied at the top, but Woods' birdie on the long 15th took him clear on his own. Another birdie on the short 16th ignited thunderous roars which reverberated around the towering pines as Woods marched off with a two-shot lead and a thousand-yard stare in scenes reminiscent of his heyday.Sporting a red mock turtleneck in a nod to his last win at Augusta in 2005, and chewing gum throughout, Woods maintained his cushion to edge world No.2 Dustin Johnson, three-time major champion Brooks Koepka and another American Xander Schauffele.When the winning putt dropped, Woods clenched his fist and punched the air to tumultuous applause, watched from behind the 18th green by his mother Kutilda, children Sam and Charlie, and girlfriend Erica Herman. 1966

The State Department ordered Wednesday the departure of non-emergency US government employees from Iraq amid increasing tensions with Iran and warned US citizens not to travel to the country, citing a "high risk for violence and kidnapping."The department said in a statement that employees working in the US embassy in Baghdad and the US consulate in Erbil were instructed to leave Iraq, and that "normal visa services will be temporarily suspended at both posts."It added that American Citizens Services employees who were working in the embassy in Baghdad "will continue to provide consular services to U.S. citizens in Basrah."The department said the sudden changes were because the US government's "ability to provide routine and emergency services to US citizens in Iraq is extremely limited" and that as a result, the threat of "terrorism, kidnapping, and armed conflict" aimed at Americans in the country was too great a risk.Secretary of State Mike Pompeo made an unannounced visit to Iraq last week amid escalating tensions with Iran.While there, Pompeo said he spoke to Iraqi officials "about the importance of Iraq ensuring that it's able to adequately protect Americans in their country."US officials have told CNN the US had "specific and credible" intelligence that suggested Iranian forces and proxies were planning to target US forces in locations including Iraq. That intelligence led the Pentagon to recommend a carrier strike group be moved to the region.The State Department also said Wednesday that Americans "should not travel through Iraq to Syria to engage in armed conflict" as they may face similar threats in Syria and face "legal risks" from both the US and Syria.The orders from the State Department come a day after US Central Command, which oversees US military operations in the Middle East, said in a statement that the Pentagon has increased the threat risk for US troops in Iraq and Syria."US Central Command, in coordination with Operation Inherent Resolve, has increased the force posture level for all service members assigned to OIR in Iraq and Syria. As a result, OIR is now at a high level of alert as we continue to closely monitor credible and possibly imminent threats to US forces in Iraq," US Navy Capt. Bill Urban, a spokesman for Central Command, said in a statement Tuesday.Urban's statement also pushed back against comments made earlier Tuesday by the deputy commander of the US-led military coalition against ISIS, UK Major Gen. Chris Ghika, who said "there has been no increased threat from Iranian backed forces in Iraq and Syria." 2598

The US House of Representatives has ordered an investigation into whether the Department of Defense experimented with ticks and other insects as biological weapons.In an amendment passed last week, the House calls for the Defense Department's Inspector General to look at whether any such experiments were done between the years 1950 and 1975.The amendment was introduced by New Jersey Rep. Chris Smith who said he was inspired to write it by "a number of books and articles suggesting that significant research had been done at US government facilities including Fort Detrick, Maryland, and Plum Island, New York, to turn ticks and other insects into bioweapons.""If true, what were the parameters of the program? Who ordered it?" Smith 749

The release of the James Bond film “No Time To Die” has been pushed back several months because of concerns about coronavirus and its impact on the global theatrical marketplace. MGM, Universal and producers Michael G. Wilson and Barbara Broccoli say Wednesday that the film would be pushed back from its April release to November 2020.“No Time To Die” will now hit theaters in the U.K. on Nov. 12 and worldwide on Nov. 25. Publicity plans for the film in China, Japan and South Korea had previously been canceled because of the outbreak. "No Time To Die" is the final film in the current series of Bond movies, which star Daniel Craig.The film will be released in the U.K. on November 12, 2020 with worldwide release dates to follow, including the US launch on November 25, 2020.— James Bond (@007) 812

来源：资阳报